v3.25.4
Noncontrolling Interest - Schedule of Net Income Attributable to Vtv Therapeutics Inc (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Noncontrolling Interest [Abstract]      
Net loss attributable to vTv Therapeutics Inc. common shareholders $ (26,974) $ (18,462) $ (20,250)
Decrease in vTv Therapeutics Inc. stockholders' equity for sale of vTv Units as a result of common stock issuances (55) (7,592) 0
Change from net loss attributable to vTv Therapeutics Inc. common shareholders and transfers to noncontrolling interest $ (27,029) $ (26,054) $ (20,250)